On Drug Pricing, The President’s Numbers Are Still Off
We checked again. The data has not changed.
The independent source for health policy research, polling, and news.
281 - 300 of 702 Results
We checked again. The data has not changed.
Here's a sampling of recent fact checks related to some of the health care claims made during President Donald Trump's Feb. 4 State of the Union speech.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
But like all of health care, it’s complicated.
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between "Medicare for All" and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
‘Medication insecurity’ is a thing.
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.
After my husband had a bike accident, we were subjected to medical bills that no one would accept if they had been delivered by a contractor, or a lawyer or an auto mechanic. Such charges are sanctioned by insurers, which generally pay because they have no way to know whether you received a particular item or service — and it’s not worth their time to investigate the millions of medical interactions they write checks for each day.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
© 2026 KFF